Consiliul Concurentei analizeaza operatiunea de concentrare economica prin care Fresenius Nephrocare Romania SRL preia controlul asupra societatilor SC Renamed Medical Service II SRL, SC Renamed Dialcare SRL, SC Renamed Nefrodial SRL si SC Renamed Nefrodiamed SRL.
Alte informaţii relevante:
Continuarea navigării presupune că ești de acord cu utilizarea cookie-urilor. Detalii
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
